Trial Profile
Safety and Pharmacokinetics of Valganciclovir Syrup Formulation in Pediatric Solid Organ Transplant Recipients
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 11 Apr 2022
Price :
$35
*
At a glance
- Drugs Valganciclovir (Primary)
- Indications Cytomegalovirus infections
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Roche
- 24 Oct 2005 New trial record.